Michigan Medicine to expand first phase of COVID-19 vaccine rollout
Michigan Medicine has expanded the first phase of their vaccine distribution.
The initial distribution of the vaccine at the University of Michigan health center included front line health care workers and students who have direct or indirect exposure to patients or other infectious material. Michigan Medicine administered over 11,000 doses of the COVID-19 vaccine in recent weeks.
Get the latest state-specific policy intelligence for the health care sector delivered to your inbox.
Expansion of Phase 1A will now include anyone who works in a clinical setting at Michigan Medicine or in the school’s health services, dentistry, nursing, social work, kinesiology, public health or pharmacy programs.
The expansion comes as stakeholders are expressing concerns about the slow pace of the U.S. vaccine distribution. Experts fear that the vaccine rollout could take ten years at the current pace. Logistical and distribution issues caused the U.S. to fall well short of the 2020 year-end 20 million dose-goal set by Operation Warp Speed.
Michigan Medicine is using Michigan stadium in Ann Arbor as a vaccine administration site to facilitate the distribution process.
“We, as a state, have a big mountain to climb with regards to the number of people who need to be vaccinated, so it is fitting that the University of Michigan has opened up the Big House for this effort,” said Preeti Malani, M.D., M.S., chief health officer at the University of Michigan.
Nearly 400,000 doses of the vaccine have been administered throughout the state of Michigan, which is just over a quarter of the state’s allocation.